Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

HIV/AIDS is a public health problem that is transmitted through risky sexual behavior. The literature suggests that the perception of HIV risk is a motivator for the prevention of risky sexual behaviors. There is no culturally adapted scale to assess HIV risk perception in the Hispanic-American population. The aim of this research was to develop a scale to assess HIV risk perception in Hispanic-American young adults. A cross-sectional instrumental design was used, with a sample of students from the Chilean city with the highest HIV rates. Participants (n = 524) were between 18 and 33 years old, of whom 51% were women, 84.4% said they were heterosexual and 43.7% said they had not been tested for HIV/AIDS. The final scale has 9 items and 2 dimensions: (1) perceived risk susceptibility and (2) perceived risk severity. The results showed that the identified structure provided adequate levels of reliability (ω > .8) and presented evidence of validity, based on the internal structure of the test (i.e., using ESEM) and on the relationship with other variables (i.e., the sexual risk behaviors scale). In addition, the results showed strong invariance between the scores for men and women. It is concluded that the HIV risk perception scale has adequate psychometric properties to assess HIV risk perception in equivalent samples.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173927PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0231558PLOS

Publication Analysis

Top Keywords

hiv risk
24
risk perception
20
assess hiv
12
risk
9
evidence validity
8
perception scale
8
young adults
8
risky sexual
8
scale assess
8
perception hispanic-american
8

Similar Publications

Background: Although there is a rising trend in both dengue cases and immunocompromised conditions, there is limited research on how common severe dengue is in immunocompromised individuals. This data is key for those advising the ever-increasing numbers of immunocompromised travellers.

Methods: We conducted a systematic review and meta-analysis of studies reporting dengue frequency or outcomes in immunocompromised populations.

View Article and Find Full Text PDF

Lomentospora prolificans (formerly Scedosporium prolificans) is an emerging fungal pathogen, affecting both immunocompromised and immunocompetent individuals. Treatment is difficult due to intrinsic resistance against multiple anti-fungal agents. We describe five patients with L.

View Article and Find Full Text PDF

The Association of Premature Atherosclerosis with Ischemic Stroke in Young People with HIV in Lusaka, Zambia.

J Stroke Cerebrovasc Dis

September 2025

Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia; Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia; Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Background: Premature atherosclerosis has been observed among people with HIV (PWH) with high risk of cerebrovascular disease. The aim of this study was to evaluate premature atherosclerosis in young PWH with and without ischemic stroke.

Methods: We conducted a prospective case-control study at the University Teaching Hospital in Lusaka, Zambia between March 2022 and October 2024, comparing young PWH with non-cardioembolic ischemic stroke (cases) with PWH without a history of stroke (controls) matched (1:2) for age, sex and race.

View Article and Find Full Text PDF

Background: Past cohort studies have examined mortality among children and young adolescents (aged 0-14 years) who have received antiretroviral therapy (ART), but no systematic reviews have been undertaken to synthesise these findings. Our study aims to provide the most comprehensive global estimates of paediatric mortality among children and adolescents receiving ART.

Methods: For this systematic review and meta-regression analysis, we searched PubMed and Embase from Jan 1, 1990 to July 31, 2024 for studies reporting mortality among children and young adolescents living with HIV who were on ART.

View Article and Find Full Text PDF